Seeking Alpha

Javelin Pharmaceuticals (JAV -28.6%) shares plummet after Hospira (HSP +0.5%) announces an...

Javelin Pharmaceuticals (JAV -28.6%) shares plummet after Hospira (HSP +0.5%) announces an extension of its tender offer to June 2. Javelin disagrees with Hospira's position that the conditions to the tender offer have not been fully satisfied. (PR)
Comments (1)
  • Tony Petroski
    , contributor
    Comments (6373) | Send Message
     
    For you marketing students: "Javelin Pharmaceuticals?" Was "Poke in the Arm Pharmaceuticals" taken?

     

    And "Hospira?" "Vampira?"

     

    Back to basics would take us to "Healthful Pharmaceuticals" and "Sound Care Hospital Supply."
    19 May 2010, 09:57 AM Reply Like
DJIA (DIA) S&P 500 (SPY)
ETF Hub
ETF Screener: Search and filter by asset class, strategy, theme, performance, yield, and much more
ETF Performance: View ETF performance across key asset classes and investing themes
ETF Investing Guide: Learn how to build and manage a well-diversified, low cost ETF portfolio
ETF Selector: An explanation of how to select and use ETFs